Evidence map

ReviewDrugs2019

Dapagliflozin: A Review in Type 2 Diabetes.

Sohita DhillonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

112 papers cite itlatest 60 shown

2019
2022
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31236801